| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |